PT Sariguna Primatirta Tbk, (CLEO) Fair Value & Analysis
Consumer Defensive · ID · Market cap 9.1T IDR
Fair value as of: Jul 14, 2026
From 24 valuation models · updated 27 days ago
Share price +3.2% over the past month.
Below-average quality, and screening another 26% overvalued on our models.
What matters now
- Weak quality (37/100) and above fair value at the same time, the margin of safety is missing on both counts.
- The model range is unusually wide (148.55 IDR to 447.23 IDR). The outcome hinges heavily on assumptions, so read the point estimate with caution.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 14, 2026.
How to read this chart
60‑month range 201.94 IDR – 821.65 IDR · fair‑value band 148.55 IDR – 447.23 IDR · the 386.00 IDR price screens above the 283.98 IDR fair value. Dashed = 300-day average. As of Jul 14, 2026.
Analysis
PT Sariguna Primatirta Tbk, (CLEO) currently trades at 386.00 IDR, while our model-based Fair Value estimate is 283.98 IDR, implying the stock looks roughly 26.4% overvalued today. The Quality Score stands at 37/100 (below-average quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, PT Sariguna Primatirta Tbk, generated revenue of 2.9T IDR at a net margin of 13.1%. Revenue grew 15.8% year over year. It earns a return on equity of 17.6%. Net debt stands at 395B IDR. Fundamentals as of Jul 14, 2026
Our scenario range runs from 148.55 IDR (bear case) to 447.23 IDR (bull case); at 386.00 IDR, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 50% below its 52-week high and 21% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -14% fair-value upside, at -26%, CLEO screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: Growth Earnings (470.72 IDR) versus Asset-Based (62.78 IDR). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 14, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 43 · Market factors (momentum, volatility) 39
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
PT Sariguna Primatirta Tbk, together with its subsidiaries, produces and sells bottled drinking water products in Indonesia. The company operates through the Bottle, Non-Bottle, and Others segments. The company also has wholesale trading of food and beverages and the production and distribution of ice for food, beverage, and other uses.
Full company description
PT Sariguna Primatirta Tbk, together with its subsidiaries, produces and sells bottled drinking water products in Indonesia. The company operates through the Bottle, Non-Bottle, and Others segments. The company also has wholesale trading of food and beverages and the production and distribution of ice for food, beverage, and other uses. It sells drinking water under the Cleo, Super O2, VIO, Cleo Plantine, Anda, and S-Tube brands; and green tea under the NOGU brand. The company was formerly known as PT Sari Guna and changed its name to PT Sariguna Primatirta Tbk in December 1988. The company was founded in 1988 and is headquartered in Sidoarjo, Indonesia. PT Sariguna Primatirta Tbk operates as a asubsidiary of PT Tancorp Global Abadi.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
PT Sariguna Primatirta Tbk, reported revenue of 2.8T IDR in FY2025 versus 1.1T IDR in FY2021, a compound +26.5%/yr. Reported net income was 382B IDR in FY2025, compounding +20.6%/yr from FY2021.
CLEO screens 26% overvalued. Compare with The Coca-Cola Company →
Peer Group
Beverages - Non-Alcoholic · 91 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Beverages - Non-Alcoholic median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Insider activity: 35/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Beverages - Non-Alcoholic stocks, each showing price versus our Fair Value estimate (as of Jul 14, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Coca-Cola Company KO | $87.05 | $36.57 | -58% |
| PepsiCo, Inc PEP | $139.02 | $106.91 | -23% |
| Monster Beverage Corporation MNST | $97.50 | $35.82 | -63% |
| Nongfu Spring Co 9633 | HK$41.44 | HK$30.72 | -26% |
| Coca-Cola Europacific Partners PLC CCEP | €92.10 | €85.41 | -7% |
| Keurig Dr Pepper Inc KDP | $31.25 | $30.99 | -1% |
| Coca-Cola FEMSA, S.A. KOF | $102.04 | $106.45 | +4% |
| Coca-Cola HBC AG EEE | €57.90 | €52.82 | -9% |
| Varun Beverages Limited VBL | ₹495.70 | ₹187.49 | -62% |
| Eastroc Beverage (Group) Co 605499 | ¥124.43 | ¥107.57 | -14% |
Compare PT Sariguna Primatirta Tbk, with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is PT Sariguna Primatirta Tbk, (CLEO) overvalued or undervalued?
What is the fair value of CLEO?
What is the quality score of CLEO?
What is the revenue of PT Sariguna Primatirta Tbk, (CLEO)?
What is the net profit margin of CLEO?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track PT Sariguna Primatirta Tbk, and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.